SCHEMBL9997644

SCHEMBL9997644

CCC(=Cc1cccc(C(C)C)c1)C(OC(C)=O)OC(C)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.37
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HDAC4 P56524 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
CYP3A4 P08684 2/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
MDM4 O15151 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
TP53 P04637 1/20 0.36
TYR P14679 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
CA5A P35218 1/20 0.36
MDM2 Q00987 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997456 0.89 PPARG (0.35) PPARGALDH1A1KDM4ESMN1; SMN2HDAC4
SCHEMBL9997778 0.86 ALDH1A1 (0.38) PPARGALDH1A1KDM4ESMN1; SMN2HDAC4
SCHEMBL9997881 0.84 LMNA (0.41) ALDH1A1KDM4ESMN1; SMN2MAPTTP53
SCHEMBL9997905 0.84 LMNA (0.41) ALDH1A1KDM4ESMN1; SMN2MAPTTP53
SCHEMBL9998113 0.84 TSHR (0.41) PPARGALDH1A1CYP3A4HTTRXRA
SCHEMBL9997286 0.83 SLC6A19 (0.47) ALDH1A1KDM4ESMN1; SMN2MAPTHTT
SCHEMBL9998385 0.83 KMT2A (0.43) ALDH1A1KDM4ESMN1; SMN2HPGDALOX15
SCHEMBL9998531 0.83 MAPT (0.48) KDM4ESMN1; SMN2MAPTLMNAGLO1
SCHEMBL9998047 0.83 ALDH1A1 (0.36) PPARGALDH1A1KDM4ESMN1; SMN2HDAC4
SCHEMBL9997480 0.83 HDAC4 (0.40) ALDH1A1KDM4ESMN1; SMN2HDAC4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 PPARG 2160/4885ALDH1A1 160/4885KDM4E 3266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.